Newsbenzinga
Pfizer Stock Trades Flat Following Mixed Phase 3 Lung Cancer Trial Data
· Published
Article summary
Pfizer shares are trading flat in Wednesday's premarket as traders weigh mixed Phase 3 trial headlines alongside a firmer overnight tape.
An excerpt from the original article.
Comments —
Loading comments…